BGN bresagen limited

no problem with export

  1. 4,315 Posts.
    lightbulb Created with Sketch. 112
    The announcement

    Australian biotechnology company BresaGen Ltd today received
    clarification about proposed changes to export and customs
    regulations following the recent Senate approval of Bills for
    Research Involving Embryos and Prohibition of Human Cloning.

    The company has been informed by the National Health and Medical
    Research Council that there is no intention to prohibit the export of
    embryonic stem cells or the products of embryonic stem cells.

    The regulatory changes only are intended to stop the export of whole
    embryos. BresaGen is encouraged by such an approach, as these changes
    will not hinder the development of embryonic stem cell based
    therapies in Australia for export to world markets.
watchlist Created with Sketch. Add BGN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.